Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.74 | 1.81 |
NAV | ₹83.45 | ₹100.82 |
Fund Started | 15 Apr 2009 | 31 Jul 2008 |
Fund Size | ₹9867.12 Cr | ₹4721.61 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year | Exit load of 1%, if redeemed within 30 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 34.68% | 39.81% |
3 Year | 18.29% | 23.34% |
5 Year | 23.46% | 23.33% |
1 Year
3 Year
5 Year
Equity | 94.59% | 97.40% |
Cash | 4.15% | 2.60% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 8.57% |
HDFC Bank Ltd. | 6.77% |
Axis Bank Ltd. | 6.04% |
Sun Pharmaceutical Industries Ltd. | 5.98% |
Larsen & Toubro Ltd. | 4.22% |
Ultratech Cement Ltd. | 3.79% |
Dabur India Ltd. | 3.41% |
Avenue Supermarts Ltd. | 3.36% |
NTPC Ltd. | 3.31% |
Info Edge (India) Ltd. | 3.31% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 6.21% |
ICICI Bank Ltd. | 5.26% |
State Bank of India | 4.04% |
Infosys Ltd. | 3.90% |
Larsen & Toubro Ltd. | 2.88% |
Bharti Airtel Ltd. | 2.83% |
Dr. Reddy's Laboratories Ltd. | 2.73% |
ITC Ltd. | 2.54% |
CESC Ltd. | 2.29% |
Biocon Ltd. | 2.21% |
Name | Vaibhav Dusad | Satish Ramanathan |
Start Date | 02 May 2020 | 01 Oct 2024 |
Name
Start Date
Description | The scheme seeks to generate capital appreciation by investing in a concentrated portfolio of equity and equity related securities of up to 30 companies across market capitalization i.e. focus on multicap. | The scheme which aims to provide capital appreciation by investing primarily in equity and equity related securities of various market depending upon valuation discount or premium amongst Large / Mid & Small cap stocks, the fund will keep varying the weights to capture the value while keeping an optimum Risk / Return profile. |
Launch Date | 15 Apr 2009 | 31 Jul 2008 |
Description
Launch Date